Evidence map›Paper›PMID 38242118›Full record

ArticleStructure (London, England : 1993)2024

The Giardia lamblia ribosome structure reveals divergence in several biological pathways and the mode of emetine function.

Daniel R Eiler, Brian T Wimberly, Danielle Y Bilodeau, J Matthew Taliaferro, Philip Reigan, Olivia S Rissland, Jeffrey S Kieft

Open access · hybridAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Structural basis for emetine inhibition of ribosome translocation inbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. High-resolution reconstruction of aRNA (New York, N.Y.) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel R EilerDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Brian T WimberlyDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Danielle Y BilodeauDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA; RNA BioScience Initiative, University of Colorado School of Medicine, Aurora, CO 80045, USA.
J Matthew TaliaferroDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA; RNA BioScience Initiative, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Philip ReiganSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Olivia S RisslandDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA; RNA BioScience Initiative, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: olivia.rissland@cuanschutz.edu.
Jeffrey S KieftDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA; RNA BioScience Initiative, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: jkieft@nysbc.org.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Structure, function, and dynamics of viral RNAs and RNA-containing complexesR35GM118070 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Jeffrey S Kieft · 2016 to 2026
$10.6M
Exploring the connections between translation and mRNA decayR35GM128680 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Olivia Selfridge Rissland · 2018 to 2026
$3.7M
Understanding the regulatory language of RNA localizationR35GM133385 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Jefferson Matthew Taliaferro · 2019 to 2026
$3.4M
Mechanisms of protein production in the parasite Giardia IambliaR21AI149210 · NIAID · UNIVERSITY OF COLORADO DENVER · PI RISSLAND, OLIVIA SELFRIDGE, WIMBERLY, BRIAN T · 2020 to 2021
$424k
NIAID NIH HHS R21 AI149210NIGMS NIH HHS R35 GM118070NIGMS NIH HHS R35 GM128680NIGMS NIH HHS R35 GM133385
6 · The paper itself

Abstract

Giardia lamblia is a deeply branching protist and a human pathogen. Its unusual biology presents the opportunity to explore conserved and fundamental molecular mechanisms. We determined the structure of the G. lamblia 80S ribosome bound to tRNA, mRNA, and the antibiotic emetine by cryo-electron microscopy, to an overall resolution of 2.49 Å. The structure reveals rapidly evolving protein and nucleotide regions, differences in the peptide exit tunnel, and likely altered ribosome quality control pathways. Examination of translation initiation factor binding sites suggests these interactions are conserved despite a divergent initiation mechanism. Highlighting the potential of G. lamblia to resolve conserved biological principles; our structure reveals the interactions of the translation inhibitor emetine with the ribosome and mRNA, thus providing insight into the mechanism of action for this widely used antibiotic. Our work defines key questions in G. lamblia and motivates future experiments to explore the diversity of eukaryotic gene regulation.

Indexed as

Giardia lambliaAnti-Bacterial AgentsCryoelectron MicroscopyEmetineHumansRibosomesRNA, MessengerAnti-Bacterial AgentsEmetineRNA, Messengercryo-electron microscopyemetineGiardia lambliaribosome quality controlribosome structuretranslation

Identifiers

PMID38242118
PMCPMC10997490
OpenAlexW4390990126

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.